Cirrhosis/Liver Failure

Top Story

Mallinckrodt completes phase 3 enrollment for hepatorenal syndrome drug

May 15, 2019

Alcohol-related hepatitis therapy lowers Lille score, bilirubin, MELD

May 13, 2019
Durect Corporation announced preliminary data from an ongoing phase 2a trial of DUR-928 for alcohol-related hepatitis, according to a press release. To date, 10 patients…
In the Journals

Advanced practice providers make difference in cirrhosis care quality

May 8, 2019
Patients with cirrhosis had improved quality of care and outcomes when treated by advanced practice providers compared with those without such care. In the study…
In the Journals

Fibrosis stages worsening in alcoholic fatty liver disease cases

May 7, 2019
Although the prevalence of alcoholic fatty liver disease among U.S. adults remained stable between 2001 and 2016, the prevalence of those with stage 2 or higher fibrosis…
More Headlines »
CME

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »
GI Bookshelf

Question 20: A 58-Year-Old Female Underwent A Screening Colonoscopy That Showed A 2.5-Cm Flat Polyp In The Proximal Ascending Colon. I Tattooed The Area And Biopsied The Polyp, Which Was Initially Reported As Hyperplastic. What Should I Do?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Video
Meeting News Coverage

MAIT cells found to be dysfunctional in patients with alcoholic liver disease

April 29, 2015
More »